Breast cancer is classified into four major molecular subtypes based on immunohistochemical classification: luminal A and luminal B (expressing the estrogen receptor (ER)), basal-like and human epidermal growth factor receptor 2 (HER2)-enriched (without ER expression) (2, 3). This evidence concerns the gene ERBB2 and breast carcinoma.